Cargando…

Evasion of Type I Interferon by SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and host immune response determine coronavirus disease 2019 (COVID-19), but studies evaluating viral evasion of immune response are lacking. Here, we use unbiased screening to identify SARS-CoV-2 proteins that antagonize type I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo, Shi, Pei-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501843/ https://www.ncbi.nlm.nih.gov/pubmed/32979938 http://dx.doi.org/10.1016/j.celrep.2020.108234

Ejemplares similares

Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response
por: Cao, Zengguo, et al.
Publicado: (2021)

Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
por: Lokugamage, Kumari G., et al.
Publicado: (2020)

An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction
por: Xia, Hongjie, et al.
Publicado: (2018)

Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
por: Bills, Cody J., et al.
Publicado: (2023)

Activation and evasion of type I interferon responses by SARS-CoV-2
por: Lei, Xiaobo, et al.
Publicado: (2020)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Shi, Pei-Yong, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

The N501Y spike substitution enhances SARS-CoV-2 transmission
por: Liu, Yang, et al.
Publicado: (2021)

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
por: Zhang, Xianwen, et al.
Publicado: (2021)

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
por: Liu, Yang, et al.
Publicado: (2021)

Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
por: Liu, Yang, et al.
Publicado: (2022)

Immune evasion of SARS-CoV-2 from interferon antiviral system
por: Min, Yuan-Qin, et al.
Publicado: (2021)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility
por: Shi, Pei-Yong, et al.
Publicado: (2020)

Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways
por: Rajsbaum, Ricardo, et al.
Publicado: (2013)

Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
por: Menachery, Vineet D., et al.
Publicado: (2014)

SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways
por: Oh, Soo-Jin, et al.
Publicado: (2022)

Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
por: Znaidia, Mariem, et al.
Publicado: (2022)

An Infectious cDNA Clone of SARS-CoV-2
por: Xie, Xuping, et al.
Publicado: (2020)

Interferon induction, evasion, and paradoxical roles during SARS‐CoV‐2 infection
por: Chiale, Carolina, et al.
Publicado: (2022)

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility
por: Plante, Jessica A., et al.
Publicado: (2020)

Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness
por: Plante, Jessica A., et al.
Publicado: (2021)

SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
por: Sacchi, Alessandra, et al.
Publicado: (2023)

Recent advances in understanding viral evasion of type I interferon
por: Taylor, Kathryne E., et al.
Publicado: (2013)

Evasion of I Interferon-Mediated Innate Immunity by Pseudorabies Virus
por: Zhang, Rui, et al.
Publicado: (2021)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
por: Hu, Yanping, et al.
Publicado: (2023)

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xie, Xuping, et al.
Publicado: (2020)

Pteropus vampyrus TRIM40 Is an Interferon-Stimulated Gene That Antagonizes RIG-I-like Receptors
por: van Tol, Sarah, et al.
Publicado: (2023)

A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory
por: Zou, Jing, et al.
Publicado: (2022)

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xie, Xuping, et al.
Publicado: (2021)

Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
por: Muruato, Antonio, et al.
Publicado: (2021)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
por: Zou, Jing, et al.
Publicado: (2022)

Ten Strategies of Interferon Evasion by Viruses
por: García-Sastre, Adolfo
Publicado: (2017)

Interferons: Signaling, antiviral and viral evasion
por: Bonjardim, Cláudio A., et al.
Publicado: (2009)

Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2
por: Xia, Hongjie, et al.
Publicado: (2020)

Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
por: Ku, Zhiqiang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mhc7bonfp69ssla28sto4qpbtn